Neurocrine Bio. (NBIX) PT Raised to $158 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Neurocrine Bio. (NBIX) PT Raised to $163 at Wedbush
August 1, 2024 12:16 PM EDTWedbush analyst Laura Chico raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $163.00 (from $152.00) while maintaining a Outperform rating.... More
Neurocrine Biosciences (NBIX) Tops Q2 EPS by 50c
August 1, 2024 7:09 AM EDTNeurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of $1.63, $0.50 better than the analyst estimate of $1.13. Revenue for the quarter came in at $580 million versus the consensus estimate of $547.1 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
... More